.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Dr. Jolly's is stocked at 78 licensed dispensaries across Oregon, with the deepest coverage in Portland, Salem, Eugene, Medford, and Ontario. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, Dr. Jolly's tilted heavily into Vapor Pens at 50.66% share while maintaining Concentrates at 29.66% and Pre-Roll at 17.59%, with Tincture & Sublingual at 2.09%. Year over year, Vapor Pens expanded 866.90% and Pre-Roll surged 5,980.88%, while Concentrates rose 178.38%; month over month, Concentrates advanced 8.54% and Tincture & Sublingual jumped 48.95% as Pre-Roll contracted 25.07% and Vapor Pens inched up 0.81%. Given a brand-level sales increase of 515.87% year over year and an average price down 25.31%, the pattern implies that mix-led volume gains—especially in Vapor Pens and Pre-Roll—offset price compression to drive outsized growth.
The mix shift concentrates demand in mid-price inhalables—Vapor Pens averaging $21.54 and Concentrates at $16.40—while the sharp month-over-month pullback in Pre-Roll alongside a 0.81% uptick in Vapor Pens suggests substitution toward higher-value inhalables rather than basket expansion. With a 30th rank in Vapor Pens within Oregon and a 24-month sales change of -24.28% against a current-year surge, the juxtaposition implies a rebound anchored in tactical pricing and category breadth; sustaining position will likely require stabilizing Pre-Roll volatility while using the 48.95% Tincture & Sublingual month-over-month rise to test incremental reach without diluting the 50.66% Vapor Pens core.
Competitive Landscape
Dr. Jolly's is ranked #30 in OR Vapor Pens in October 2026, improving 48 positions year over year from #78, while holding flat versus three months ago at #30; this sits 5 spots below its historical peak of #25 from November 2024 and trails category leaders where Entourage Cannabis / CBDiscovery maintained #1 with a -12.4% YoY sales change and FRESHY climbed from #5 to #3 with +11.9% YoY growth. Compared with mid-pack movers like Loot Bar, which advanced from #8 to #5 on +24.5% YoY sales, Dr. Jolly's stability at #30 despite a 48-rank YoY rise indicates distribution or velocity gains have plateaued recently, implying the brand’s trajectory points to consolidation rather than continued climb without a new activation to break through the #25–#30 band.
Notable Products
October 2026 was driven by fresh launches: new products accounted for 66.5% of Dr. Jolly's sales, with items like Dogwalker x Blue Dream Pre-Roll 10-Pack (5g) and Lizard Burger Live Resin Cartridge (1g) among the top sellers. That concentration in recent additions means most of the brand’s sales come from items introduced in the last six months.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
